The Cardiac Array utilises cutting-edge biochip array technology to simultaneously measure four cardiac biomarkers and provide results within 30 minutes. It offers a comprehensive biochemical profile of patients presenting to hospital with chest pain and suspected acute coronary syndrome.

The Cardiac Array can be used with Randox's rapid testing platform, Evidence MultiStat, which can be placed in the Emergency Department, Cardiology clinic or central Biochemistry laboratory. MultiStat provides highly accurate and precise "near-patient" results that can be fully trusted by consultants and aid the clinical management of patients.

Studies have shown that the Cardiac Array offers:

• 98% NPV at 3-6 hours post chest pain onset 11
• 20% improved diagnostic sensitivity during the early hours after presentation, compared to Troponin alone 11

Furthermore, studies have shown that H-FABP offers:

• Elevated levels as early as 30 minutes after symptom onset 6
• 0% mortality up to 6 months, when combined with a negative Troponin result 5
• Improved risk stratification of Troponin negative patients, even when a modern high sensitivity Troponin assay is used 10

Cardiac Markers